EssilorLuxottica SA
Healthcare · EUR · EPA
Price
€174.775
Cap
€76.87B
Earnings
—
30d Trend
-3.6%
32% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 29×Macro 0.99 (−1%)=29
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate EssilorLuxottica SA at 29/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 43/100. I classify this as a defensive position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-2.1%
3 MONTHS
-20.6%
12 MONTHS
-27.8%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Technical (43) and low-risk profile are the primary strengths. I note that quality is the weakest area at 15/100 — this warrants monitoring. Historical volatility is moderate at 32%. I classify this as a defensive holding — stability characteristics and resilient fundamentals provide portfolio ballast.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.